Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000261549 corresponds to a pseudogene of the CAPZA2 gene, which encodes the F-actin-capping protein subunit alpha-2 in its protein-coding form. As a pseudogene, ENSG00000261549 does not produce a functional protein and has no established biological function, clinical relevance, or pharmacological targeting potential. The functional CAPZA2 protein plays a role in capping actin filaments at the Z-line in muscle, but this does not apply to its pseudogene copy[9][1]. Summary of what’s incorrect or missing: - This entry is a pseudogene, not a functional molecule or receptor. - It is not a therapeutic target. - There are no known interacting drugs, disease associations, or biological activities. The gene ENSG00000261549 should not be used when searching for functional or therapeutic targets; instead, focus should be on "CAPZA2" (F-actin-capping protein subunit alpha-2) for research on actin capping proteins[1][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Capping protein (actin filament) muscle Z-line, alpha 2 pseudogene.